Daniel Corey
Directeur Général chez CERo Therapeutics, Inc.
Fortune : 946 773 $ au 30/04/2024
Profil
Daniel Mark Corey is the founder of CERo Therapeutics, Inc. which was founded in 2018.
He holds the title of Chief Executive & Technology Officer at CERo Therapeutics, Inc. Currently, Dr. Corey is the Director & Chief Technical Officer at CERo Therapeutics Holdings, Inc. since 2021.
Dr. Corey's education includes an undergraduate degree from Brown University and a doctorate degree from UW Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
4,56% | 05/04/2024 | 671 470 ( 4,56% ) | 946 773 $ | 30/04/2024 |
Postes actifs de Daniel Corey
| Sociétés | Poste | Début |
|---|---|---|
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. BiotechnologyHealth Technology CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Directeur Général | 01/01/2018 |
Formation de Daniel Corey
| Brown University | Undergraduate Degree |
| UW Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. BiotechnologyHealth Technology CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Health Technology |